Clinical trials
Phase 2 Food Hypersensitivity trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 4 |
| Terminated | 4 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of North Carolina, Chapel Hill | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Johns Hopkins University | 4 |
| DBV Technologies | 2 |
| Hugh A Sampson, MD | 2 |
| Aimmune Therapeutics, Inc. | 1 |
| Andrew J Long, PharmD | 1 |
| Andrew Long, PharmD | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Food Hypersensitivity | 34 |
| Peanut Hypersensitivity | 14 |
| Hypersensitivity | 8 |
| Hypersensitivity, Immediate | 4 |
| Milk Hypersensitivity | 4 |
| Dermatitis, Atopic | 3 |
| Eczema | 2 |
| Egg Hypersensitivity | 2 |
| Nut Hypersensitivity | 2 |
| Anaphylaxis | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.